[Trial use of L-dopa associated with a dopa-decarboxylase inhibitor in Parkinson's syndrome].
作者信息
Carotti A, Tomassetti G, Lucciarini L, Barone G, Mugnai A
出版信息
Clin Ter. 1974 Jul 15;70(1):9-15.
PMID:4153252
Abstract
摘要
相似文献
1
[Trial use of L-dopa associated with a dopa-decarboxylase inhibitor in Parkinson's syndrome].
Clin Ter. 1974 Jul 15;70(1):9-15.
2
[Results after 3 to 5 years of treatment of 219 cases of Parkinson's syndrome treated by L-Dopa and an L-Dopa -decarboxylase inhibitor combination].[左旋多巴与左旋多巴脱羧酶抑制剂联合治疗219例帕金森综合征3至5年的结果]
Rev Neurol (Paris). 1974 Jul-Aug;130(7-8):273-84.
3
[Variation in the pharmacologic affects of decarboxylase inhibitor in variable doses in man].
Biomedicine. 1974 Dec 10;21(12):486-90.
4
[Decarboxylase inhibitors combined with L-dopa in the treatment of Parkinson's disease].[脱羧酶抑制剂与左旋多巴联合用于帕金森病的治疗]
Rev Prat. 1974 Mar 11;24(15):1211-2, 1215-6, 1219.
5
How to achieve maximum benefit for the patient with Parkinson's disease.如何为帕金森病患者实现最大益处。
Geriatrics. 1976 Apr;31(4):89-96.
6
The pharmacology of parkinsonism (a review).帕金森病药理学（综述）
Dis Nerv Syst. 1968 Dec;29(12):805-16.
7
Parkinson's disease improvement after the addition of levodopa-carbidopa to anticholinergic treatment. An open controlled study.
Acta Neurol (Napoli). 1978 Oct;33(5):436-42.
8
9
10
[Treatment of Parkinson's syndrome using a new preparation from the series of tricyclic psychotropic drugs].[使用三环类精神药物系列中的一种新制剂治疗帕金森综合征]
Med Welt. 1975 Aug 22;26(33-34):1457-62.
Zotero 插件